{"name":"Fujian Akeylink Biotechnology Co., Ltd.","slug":"fujian-akeylink-biotechnology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"GST-HG131","genericName":"GST-HG131","slug":"gst-hg131","indication":"Advanced solid tumors","status":"phase_2"},{"name":"GST-HG141","genericName":"GST-HG141","slug":"gst-hg141","indication":"Advanced solid tumors (Phase 3 development)","status":"phase_3"}]}],"pipeline":[{"name":"GST-HG131","genericName":"GST-HG131","slug":"gst-hg131","phase":"phase_2","mechanism":"GST-HG131 is a small molecule targeting the HIF-1α pathway.","indications":["Advanced solid tumors"],"catalyst":""},{"name":"GST-HG141","genericName":"GST-HG141","slug":"gst-hg141","phase":"phase_3","mechanism":"GST-HG141 is a bispecific antibody that simultaneously engages two distinct immune checkpoints to enhance anti-tumor T-cell responses.","indications":["Advanced solid tumors (Phase 3 development)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}